3-(5-(1-Benzylpiperidin-4-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Catalog No. :
ACYVZI975
CAS No. :
2291360-73-9
Molecular Formula :
C25H27N3O3
Molecular Weight :
417.51

IUPAC Name:3-(5-(1-benzylpiperidin-4-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione

3-(5-(1-Benzylpiperidin-4-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg98%$50.00Login to see priceIn stockInquiry
25mg98%$92.00Login to see priceIn stockInquiry
50mg98%$155.00Login to see priceIn stockInquiry
100mg98%$263.00Login to see priceIn stockInquiry
250mg98%$498.00Login to see priceIn stockInquiry
1g98%$1342.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(5-(1-Benzylpiperidin-4-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
IUPAC Name3-(5-(1-benzylpiperidin-4-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
Molecular FormulaC25H27N3O3
Molecular Weight417.51
SMILESO=C(C(N(CC1=C2C=CC(C3CCN(CC4=CC=CC=C4)CC3)=C1)C2=O)CC5)NC5=O
InChI KeyOMISHRJQMYQPMG-UHFFFAOYSA-N
Synonymcompound 5;DKY-709;DKY709
CAS No.2291360-73-9
PubChem CID137519326

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACYVZI975 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTDWF398 route compound structure diagram
    ACTDWF3982291360-60-4 In Stock
  2. Then
  3. ACYVZI975 route product structure diagram
    ACYVZI9752291360-73-9 In Stock
Inquiry

2. ACYVZI975 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYVZI975 route product structure diagram
    ACYVZI9752291360-73-9 In Stock
Inquiry

Comments (0)